Valuation : BioAdaptives, Inc.

Market Cap 236K 203K 191K 175K 326K 22.4M 327K 2.27M 876K 11.45M 887K 868K 36.29M P/E 2024
-0.55x
P/E 2025 -0.14x
Enterprise Value 462K 398K 374K 341K 637K 43.83M 640K 4.43M 1.71M 22.4M 1.74M 1.7M 71M EV / Sales 2024
55.1x
EV / Sales 2025 26.9x
Free-Float
5.04%
Yield 2024 *
-
Yield 2025 -
1 day+5.26%
1 week-7.69%
Current month-7.69%
1 month-57.82%
3 months-83.31%
6 months-92.00%
Current year-94.57%
1 week 0
Extreme 0.001
0
1 month 0
Extreme 0.001
0
Current year 0
Extreme 0.0008
0.03
1 year 0
Extreme 0.0008
0.07
3 years 0
Extreme 0.0008
0.81
5 years 0
Extreme 0.0008
7.28
10 years 0
Extreme 0.0008
108
Manager TitleAgeSince
Chief Executive Officer 55 2024-05-20
Investor Relations Contact - -
Corporate Officer/Principal 63 -
Director TitleAgeSince
Director/Board Member 53 2024-05-29
Chairman 55 2024-05-20
Director/Board Member 70 2025-02-02
Date Insider Type Main position Quantity % Market Cap. Importance
2/15/25 Buy

Director

1 0.0000%
11/22/24 Buy

Director

125,000 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
+5.26%-7.69%-97.07%-99.76% 224K
+0.53%-1.37%+10.76%+64.20% 12.12B
-0.62%+2.13%-21.08%+317.64% 9.42B
+0.31%+0.61%-19.44%-48.11% 2.45B
+0.89%+3.59%-14.72%-3.24% 1.53B
+0.09%-0.53%+22.23%+82.46% 1.36B
+0.40%+13.10%+26.06%-12.46% 1.3B
-5.77%-9.10%-75.19%-75.92% 1.21B
-1.16%-0.90%-39.81% - 1.13B
-6.03%-6.03%-62.18%-67.39% 1.01B
Average -0.61%-1.79%-27.04%+17.49% 3.15B
Weighted average by Cap. -0.35%+0.45%-8.66%+117.87%

Financials

2024 2025
Net sales 12.67K 10.9K 10.25K 9.36K 17.46K 1.2M 17.55K 121K 46.96K 614K 47.57K 46.53K 1.95M 18.28K 15.72K 14.79K 13.5K 25.18K 1.73M 25.32K 175K 67.75K 886K 68.63K 67.13K 2.81M
Net income -899K -773K -727K -664K -1.24M -85.25M -1.25M -8.62M -3.33M -43.58M -3.38M -3.3M -138M -1.56M -1.34M -1.26M -1.15M -2.15M -148M -2.16M -14.93M -5.77M -75.5M -5.85M -5.72M -239M
Net Debt 206K 177K 166K 152K 283K 19.49M 285K 1.97M 762K 9.97M 772K 755K 31.58M 226K 194K 183K 167K 311K 21.42M 313K 2.17M 838K 10.95M 849K 830K 34.71M
Logo BioAdaptives, Inc.
BioAdaptives, Inc. operates in the health and wellness industry. The Company’s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.
Employees
1
Date Price Change Volume
26-09-08 US$0.001200 +5.26% 20,101,723
26-09-04 US$0.001140 +3.64% 4,355,713
26-09-03 US$0.001100 +1.85% 11,799,377
26-09-02 US$0.001080 -1.82% 7,432,511
26-09-01 US$0.001100 -15.38% 22,542,487
  1. Stock Market
  2. Stocks
  3. BDPT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!